U.S. drugmaker Eli Lilly will continue selling its innovator diabetes and obesity drug at premium prices in India even as the market prepares for the arrival of lower-priced generic drugs. The company says it is not planning price reduction...
NATCO Pharma launches generic Pomalidomide capsules in the US for blood and bone marrow cancer, strengthening its oncology portfolio and improving patient access to treatment.
The Medicity has launched a public awareness campaign to shift the focus from seasonal concern over air pollution to continuous monitoring and prevention of chronic respiratory diseases (CRDs).
Sai Life Sciences is gaining momentum as India’s pharma boom drives demand for drug development and manufacturing services, posting strong revenue and profit growth in 2026.
MedGenome invests in Medcare to strengthen India’s integrated diagnostics ecosystem, combining advanced imaging, pathology, and genomics for better early disease detection.
The ongoing Gulf conflict is disrupting India’s medical tourism and pharma exports, causing flight cancellations, rising shipping costs, and delays that threaten revenue for hospitals and drug manufacturers.
India has reopened the Pharma PLI scheme for select bulk drugs, giving manufacturers another chance to secure incentives and scale up domestic API production.
Emcure partners with Roche to improve access to life-saving nephrology and transplant treatments in India. The collaboration expands care for CKD, anemia, and organ transplants.
The FDA has approved Ascendis Pharma’s Yuviwel, a once-weekly treatment for children with achondroplasia. The new therapy offers an alternative to daily injections and showed strong growth results in clinical trials.
MGM Healthcare has launched Swayam, Chennai's first comprehensive multidisciplinary geriatric programme. This structured continuity-of-care model integrates outpatient, inpatient, and home-based services to restore and sustain quality of life...